#pharma stocks

1 story

#amgen #biotech #business #clinical trials #finance #lp(a)

Amgen fell on someone else's failed drug
Novartis missed on pelacarsen, and $12 billion came off Amgen for a bet it hasn't run yet.
Yahoo Finance · 1m